Business
Statins could help prevent cardiovascular disease
Cardiovascular diseases, also known under the acronym CVD, are a group of conditions that affect the heart or blood vessels. This range of conditions includes heart failure, carditis, stroke, hypertensive heart disease, cardiomyopathy, heart arrhythmia, valvular heart disease etc.
Cardiovascular diseases, also known under the acronym CVD, are a group of conditions that affect the heart or blood vessels. This range of conditions includes heart failure, carditis, stroke, hypertensive heart disease, cardiomyopathy, heart arrhythmia, valvular heart disease etc.
Risk factors for cardiovascular disease are obesity, inactivity, high blood pressure or high cholesterol, immoderate smoking or alcohol consumption, as well as poor nutrition. Experts advise that the prevention of all cardiovascular diseases must include healthy diet and every day exercise. However, for people at the age between 40 and 50 years who are at risk for cardiovascular disease the use of a statin along with a healthy nutrition and exercise could be also a way to fight against stroke or heart arrhythmia, among other heart conditions.
Experts from the U.S. Preventative Services Task Force who analyze all the latest scientific evidence recommend people with high blood pressure, cholesterol or diabetes and those who have a greater chance of having a heart attack or stroke to exercise more, eat healthy but also to use a statin for preventing cardiovascular disease.
HMG-CoA reductase inhibitors, also known as statins are a group of lipid-lowering medications. Studies and researches have found statins helpful in reducing the risks of cardiovascular diseases. Evidence have shown that statins could help treat CVD in the early stages.
Continue Reading
-
Cannabis1 week ago
Coffee Shops in Only 10 Dutch Cities Will Sell Legal Cannabis from April 2025
-
Markets2 weeks ago
Bitcoin Booms, Gold Struggles, and Markets Soar: Highlights from November’s Economic Pulse
-
Markets5 days ago
Cotton Prices Decline Amid U.S. Tariffs, Weak Chinese Demand, and Strong U.S. Production Outlook
-
Biotech2 weeks ago
Cogesa and Croma Gio.Batta Merge, Unlocking 15% Growth and Accelerating Investments
You must be logged in to post a comment Login